Abstract:[Background] The WNT/β-catenin signaling pathway is a major oncogenic pathway of human hepatocellular carcinoma (HCC). More than 50% of HCCs have aberrant activation of WNT/β-catenin signaling, which are caused by genetic alterations, ligand activation, or cross-activation by other signaling pathways. We hypothesized that activating mutation of CTNNB1, the coding gene of β-catenin, may confer sensitivity to WNT/β-catenin inhibitors in HCC cells. [Materials and Methods] SNU398 is a human HCC cell line harboring a missense somatic mutation in exon 3 of CTNNB1 gene, resulting in S37C mutation. Huh7, HepG2, PLC5, and Hep3B are HCC cells containing no somatic mutations in exon 3 of CTNNB1 gene. HCC cells were treated with various types of WNT/β-catenin pathway inhibitors, including ICG-001 which down-regulates β-catenin/TCF transcriptional activity by interfering the binding of β-catenin with its transcriptional activation complex, XAV939 which targets tankyrases and facilitates degradation of β-catenin, and LGK974 which inhibits Porcupine, an acyltransferase responsible for palmitoylation and secretion of Wnt ligands, and evaluated for in vitro viability by MTT. [Results] ICG-001 as a single agent showed significantly greater anti-proliferation effect in SNU398 than other HCC cells. The 50%-inhibitory concentrations (IC50s) of ICG-001 were 5 μM and >10 μM for SNU398 and other HCC cells, respectively. ICG-001 also induced a more potent suppression of colony- formation, and a more significant increase of subG1 fraction detected by flow cytometry in SNU398 cell than other HCC cells. XAV939 up to 20 μM induced only modest anti-proliferative effect in all HCC cells. However, SNU398 remained the one showing the greatest sensitivity to the growth suppression induced by XAV939. The anti-proliferative effect of LGK974 was modest and showed no significant difference among different HCC cells. [Conclusion] The activating mutation of β-catenin may confer sensitivity to certain WNT/β-catenin pathway inhibitors, such as ICG-001, in HCC cells. (This study was supported by grants NRPB-100CAP1020-2). Citation Format: Hsiao-Hui Lin, Wen-Chi Feng, LI-Chun Lu, Ta-Wen Hsu, Ann-Lii Cheng, Chih-Hung Hsu. Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2625. doi:10.1158/1538-7445.AM2014-2625

Β-Catenin Regulates Vitamin C Biosynthesis and Cell Survival in Murine Liver

Regucalcin is a Novel Target of Beta‐catenin in Liver

Regucalcin/SMP‐30 is Regulated by Β‐catenin in the Liver

β-Catenin is temporally regulated during normal liver development

Smp30/Regucalcin Is A Direct Transcriptional Target Of Wnt Signaling In The Liver

Increased Sensitivity To Wnt/Beta-Catenin Inhibitors In Hepatocellular Carcinoma Cells Harboring Activating Mutation Of Beta-Catenin

Β‐catenin is Essential for Liver Regeneration Following Acetaminophen‐induced Acute Liver Failure.

Β-Catenin Promotes Regulatory T-cell Responses in Tumors by Inducing Vitamin A Metabolism in Dendritic Cells.

Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury.

Role of Β-Catenin in Regulating the Balance Between TNF-α- and Fas-induced Acute Liver Injury

beta-Catenin is critical for early postnatal liver growth.

Beta-catenin/TCF complex regulates HNF4-alpha expression in the liver

Correction to: USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization

Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Calpain Induces N-terminal Truncation of β-Catenin in Normal Murine Liver Development: DIAGNOSTIC IMPLICATIONS IN HEPATOBLASTOMAS

Β-Catenin Disruption Decreases Macrophage Exosomal Α-Snap and Impedes Treg Differentiation in Acute Liver Injury.

Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease

Stabilized Β-Catenin Extends Thymocyte Survival by Up-Regulating Bcl-xL

Subcellular Localization of Mutated Β-Catenins with Different Incidences of Cis-Peptide Bonds at the Xaa246-P247 Site in HepG2 Cells.

537 Reg IV Induces β-Catenin Nuclear Translocation to Induce Cell Proliferation in Human Colon Adenocarcinomas